João Costa-Rodrigues

Prof. Dr. João Costa-Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Food Chemistry
Verified
Journal Article
Closed access
JCJoão Costa-Rodrigues
João Costa-Rodrigues
OPOlívia Pinho
Olívia Pinho
PMPedro Monteiro
Pedro Monteiro

28 September 2012 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Margarida CostaMargarida Costa
Margarida Costa
JCJoão Costa-Rodrigues
João Costa-Rodrigues
MFMaria Helena V Fernandes
Maria Helena V Fernandes
PBPiedade Barros
Piedade Barros
Vitor VasconcelosVitor Vasconcelos
Vitor Vasconcelos
Rosário MartinsRosário Martins
Rosário Martins
Marine cyanobacteria have been considered a rich source of secondary metabolites with potential biotechnological applications, namely in the pharmacological field. Chemically diverse compounds were found to induce cytoxicity, anti-inflammatory and antibacterial activities. The potential of marine cyanobacteria as anticancer agents has however been the most explored and, besides cytotoxicity in tumor cell lines, several compounds have emerged as templates for the development of new anticancer drugs. The mechanisms implicated in the cytotoxicity of marine cyanobacteria compounds in tumor cell lines are still largely overlooked but several studies point to an implication in apoptosis. This association has been related to several apoptotic indicators such as cell cycle arrest, mitochondrial dysfunctions and oxidative damage, alterations in caspase cascade, alterations in specific proteins levels and alterations in the membrane sodium dynamics. In the present paper a compilation of the described marine cyanobacterial compounds with potential anticancer properties is presented and a review on the implication of apoptosis as the mechanism of cell death is discussed.

13 December 2016 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
ADAna Rita Dias
Ana Rita Dias
JCJoão Costa-Rodrigues
João Costa-Rodrigues
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Ricardo FerrazRicardo Ferraz
Ricardo Ferraz
CPCristina Prudêncio
Cristina Prudêncio

12 August 2013 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
JCJoão Costa-Rodrigues
João Costa-Rodrigues
SRSara Reis
Sara Reis
STSónia Teixeira
Sónia Teixeira
SLSandra Lopes
Sandra Lopes
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Proton pump inhibitors (PPIs), a class of molecules that are used to decrease gastric acid production, might have adverse effects on bone metabolism. The aim of this study was to characterize the concentration‐dependent and time‐dependent effects of three PPIs (omeprazole, esomeprazole, and lansoprazole) on human osteoclast precursor cells isolated from peripheral blood, and on human mesenchymal stem cells (osteoblast precursors). Cell cultures were characterized for total protein content, apoptosis, and several osteoclastic/osteoblastic features, and also for the involvement of some intracellular signaling pathways. PPIs caused a dose‐dependent decrease in cellular density, which correlated with an increase in the apoptosis rate, effects that became statistically significant at concentrations ≥ 10−5 m. They also inhibited phenotype‐related gene expression and functional parameters. For both cell types, cellular function, i.e. osteoclastic resorption and the formation of mineralized deposits by osteoblastic cells, was more affected than proliferation‐related parameters. The three PPIs showed similar qualitative and quantitative effects, but displayed some differences in the underlying intracellular signaling pathways. These results suggest that PPIs might have a direct deleterious effect on bone cells, with the possibility of decreased bone turnover.

1 March 2006 in Journal of Molecular Biology
Verified
Journal Article
Open access
ACAndreia F. Carvalho
Andreia F. Carvalho
JCJoão Costa-Rodrigues
João Costa-Rodrigues
Isabel CorreiaIsabel Correia
Isabel Correia
JPJoão da Costa Pessoa
João da Costa Pessoa
TFTiago Q. Faria
Tiago Q. Faria
JAJorge Azevedo
Jorge Azevedo
Targeting of most newly synthesised peroxisomal matrix proteins to the organelle requires Pex5p, the so-called PTS1 receptor. According to current models of peroxisomal biogenesis, Pex5p interacts with these proteins in the cytosol, transports them to the peroxisomal membrane and catalyses their translocation across the membrane. Presently, our knowledge on the structural details behind the interaction of Pex5p with the cargo proteins is reasonably complete. In contrast, information regarding the structure of the Pex5p N-terminal half (a region containing its peroxisomal targeting domain) is still limited. We have recently observed that the Stokes radius of this Pex5p domain is anomalously large, suggesting that this portion of the protein is either a structured elongated domain or that it adopts a low compactness conformation. Here, we address this issue using a combination of biophysical and biochemical approaches. Our results indicate that the N-terminal half of Pex5p is best described as a natively unfolded pre-molten globule-like domain. The implications of these findings on the mechanism of protein import into the peroxisome are discussed.

16 July 2015 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
Ricardo FerrazRicardo Ferraz
Ricardo Ferraz
JCJoão Costa-Rodrigues
João Costa-Rodrigues
MFMaria Helena V Fernandes
Maria Helena V Fernandes
MSMiguel M Santos
Miguel M Santos
IMIsabel M Marrucho
Isabel M Marrucho
Luis BrancoLuis Branco
Luis Branco